Macchiarini and Karolinska: the biomedical ethics meltdown
Paolo Macchiarini, the charismatic star surgeon and stem cell pioneer, once lauded for saving lives of suffocating patients, is now reallyContinue Reading
Tag: Medicine
OA publishers Hindawi vs. Frontiers: similar, yet different
In this article, I will compare editorial policies of two for-profit open access (OA) publishers, Frontiers and Hindawi. Though bothContinue Reading
PACE trial and other clinical data sharing: patient privacy concerns and parasite paranoia
Data sharing is all over academic news now. We had Research Parasites, a noxious species of scientists who want toContinue Reading
Zombie Scientists
There are zombie papers, those are the long-discredited or even misconduct-riddled publications, which somehow avoid retractions and continue contaminating scientificContinue Reading
Research “parasitism” and authorship rights
Two seemingly opposing medical editorials on the subject of data sharing have recently been published. One, by the International CommitteeContinue Reading
No laughing matter
A small, highly specialized medical journal makes its first attempt at satire in 21 years. The New Year’s Eve spoof paperContinue Reading
Stem cell cures for everything, Made in Germany by TICEBA
The Heidelberg-based company TICEBA (abbreviated from Tissue & Cell Banking) is not your ordinary run-of-the-mill cell bank. This German company,Continue Reading
Is Piero Anversa heading to Cardiocentro Ticino in Switzerland?
This is a brief NEWS post. Harvard stem cell researcher, Piero Anversa, has left his job with Brigham & Womens Hospital,Continue Reading
Join the Committee, ignore Publication Ethics
What we often perceive as independent quality certificates of publishing ethics are sometimes apparently nothing more than a fig leaf. This isContinue Reading
Is Frontiers a potential predatory publisher?
The Lausanne-based publishing house Frontiers, founded by the neuroscientists Henry and Kamila Markram, has been added to the Beall’s List of potential, possible, or probable predatory scholarly open-access publishers. Was this decision justified? I wish to share here some of my recent investigations.
For Better Science 